| Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, today announced that it has secured £3.5m in new equity financing, including £2.5m from lead investor |
World's... scisyhp wen kcolnu dluoc tahtObama,... sisongaid recnac s'nediB ot tcRespect... ssergnoC stsabmaL PJB ,woR eviThe... dlehdnah gnimag 3beW derewop-nWho... sweJ gninetaerht fo desucca ,iBelkin... weiver SPP htiw regrahC llaW WNVIDIA... pihC adA 601DA serutaeF ,UPGNew... semoh CTL nur-otnoroT ni sroinThe... bnb eraC :yaW nainucnaM ehTLife... syaD yrtsudnI ALFFI dednapxE t